amr

Antimicrobial Resistance

We, sectors and countries, all share responsibility in the development of antimicrobial resistance. It is by addressing this global threat together that we will manage to protect human and animal health, and therefore, our future.

Dr Monique Eloit, Director General of the OIE.

Americas region actions against AMR

PVS SCORES

Most of the countries, which developed a PVS Mission, scored 3 or higher out of 5 on ability to regulate veterinary products.

OIE QUESTIONNAIRE

19 countries answered the OIE global questionnaire on the Use of Antimicrobial Agents in animals in 2016 (66%).

ENGAGEMENT

27 countries have a Focal Point for Veterinary Products.

ACTION PLANS

6 countries developed National Action Plans, many others are developing them.

CAMEVET

Workshop on Antimicrobial Resistance at the last Seminar of the American Committee Veterinary Medicinal Products (CAMEVET).

Other activities in the Americas

 

  1. Participation of the Americas Region in the OIE Global Conference on Antimicrobial Resistance
  1. Resistance to antimicrobials from the ”One Health” perspective
  1. OIE annual report on the use of antimicrobial agents in animals: “Understanding the global situation better” (2016 and 2017)
  1. Meeting of the National Antimicrobial Resistance Control Commission of Argentina
  1. World Antibiotic Awareness Week

 

Commitments of the Member Countries in the framework of the Global Plan of Action against Antimicrobial Resistance:

  1. Improve awareness and understanding regarding antimicrobial resistance.
  2. Improve the surveillance of Antimicrobial Resistance and the Antimicrobial Use; contribute to the OIE global database on AMU.
  3. Implement best practices to reduce the use of Antimicrobialals.
  4. Legislate to ensure dispensing of antibiotics only by accredited professionals.
  5. Develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.

Global Action Plan on Antimicrobial Resistance

Read the action plan

About antimicrobial resistance

Antimicrobial agents are medicines used to treat infections, particularly those of bacterial origin. These medicines are essential to protect human and animal health, as well as animal welfare. Excessive or inappropriate use can lead to the emergence of resistant bacteria which do not respond to antibiotic treatment, as seen in recent decades. This phenomenon, called antimicrobial resistance, which poses a threat to disease control throughout the world, is a primary concern for human and animal health.

It is by ensuring the responsible and prudent use of these invaluable medicines in animals, in accordance with the intergovernmental standards of the OIE that we will be able to safeguard their efficacy.

To achieve this, coordinated action between the human and animal health and environmental sectors is crucial.

Veterinarians are part of the solution; but they must be well trained and well supervised by the statutory veterinary bodies created by law.

Antimicrobial agents are a global public good.

We each have a role to play in the fight against antimicrobial resistance and, in so doing, can protect the efficacy of these vital treatments and, by the same token, our future.

To know more about the OIE work against the Antimicrobial Resistance, enter here.